Skip to main content

Advertisement

Log in

Circ-ATIC Serves as a Sponge of miR-326 to Accelerate Esophageal Squamous Cell Carcinoma Progression by Targeting ID1

  • Original Article
  • Published:
Biochemical Genetics Aims and scope Submit manuscript

Abstract

In the previous studies, circular RNA (circRNA) has been shown to be closely related to the occurrence and development of various cancers. However, the role and mechanism of circ-ATIC in the progression of esophageal squamous cell carcinoma (ESCC) is not yet clear. Quantitative real-time PCR was used to detect the expression levels of circ-ATIC, microRNA (miR)-326 and inhibitor of DNA binding 1 (ID1) in tissues (n = 50) and cells. Cell counting kit 8 assay, colony formation assay, flow cytometry, wound-healing assay and transwell assay were performed to measure the proliferation, apoptosis, migration, and invasion of cells. In addition, the oxidative stress of cells was evaluated by detecting the productions of superoxide dismutase and malondialdehyde. Animal studies were implied to explore the role of circ-ATIC in ESCC tumor growth. The relationship between circ-ATIC and miR-326 or ID1 was determined by dual-luciferase reporter assay and RNA immunoprecipitation assay. Additionally, the protein expression of ID1 was examined by western blot assay. Circ-ATIC was found to be upregulated in ESCC tissues and cells. Silenced circ-ATIC suppressed the proliferation, migration, invasion, promoted the apoptosis and oxidative stress of ESCC cells. The tumor growth of ESCC also was inhibited by circ-ATIC knockdown. Furthermore, we found that circ-ATIC could sponge miR-326, and miR-326 could target ID1. The rescue experiments revealed that miR-326 inhibitor could reverse the negative regulation of circ-ATIC silencing on ESCC progression, and ID1 overexpression also inverted the inhibitory effect of miR-326 on ESCC progression. In addition, we confirmed that the expression of ID1 was positively regulated by circ-ATIC. Our study showed that circ-ATIC facilitated the progression of ESCC by regulating the miR-326/ID1 axis, indicating that circ-ATIC might be a target for ESCC treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Data Availability

All data generated or analyzed during this study are included in the article.

Abbreviations

ESCC:

Esophageal squamous cell carcinoma

ID1:

Inhibitor of DNA binding 1

References

Download references

Acknowledgements

We would like to thank all the patients and family members participating in this work for their cooperation and patience. This study was supported by Shijiazhuang No.1 Hospital.

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Author information

Authors and Affiliations

Authors

Contributions

BZ participated in the design of the work, methodology, data interpretation, carried out the statistical analysis and drafted the manuscript. WC and ZL participated in the methodology, data interpretation, and analysis for the work. YZ, QZ and BL participated in data interpretation and methodology. JL and CL performed the experiments and analyzed and interpreted the data. XZ analyzed interpreted the data. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Xiaojian Zhao.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Approval

The design of this protocol follows the tenets of the Declaration of Helsinki, approved by the Ethics Committee of Shijiazhuang No.1 Hospital. (No. SJZ-20201643).

Consent for Publication

All patients in this study provided their consent for publication.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, B., Chu, W., Li, Z. et al. Circ-ATIC Serves as a Sponge of miR-326 to Accelerate Esophageal Squamous Cell Carcinoma Progression by Targeting ID1. Biochem Genet 60, 1585–1600 (2022). https://doi.org/10.1007/s10528-021-10167-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10528-021-10167-3

Keywords

Navigation